Cargando…
Uracil-tegafur vs fluorouracil as postoperative adjuvant chemotherapy in Stage II and III colon cancer: A nationwide cohort study and meta-analysis
We conducted a population-based cohort study enrolling patients with Stage II and III colon cancer receiving postoperative adjuvant chemotherapy with uracil and tegafur (UFT) or fluorouracil (5-FU) from the Taiwan National Health Insurance Research Database from 2000 to 2015. The outcomes of the cur...
Autores principales: | Chen, Po-Huang, Wu, Yi-Ying, Lee, Cho-Hao, Chung, Chi-Hsiang, Chen, Yu-Guang, Huang, Tzu-Chuan, Yeh, Ren-Hua, Chang, Ping-Ying, Dai, Ming-Shen, Lai, Shiue-Wei, Ho, Ching-Liang, Chen, Jia-Hong, Chen, Yeu-Chin, Hu, Je-Ming, Yang, Sung-Sen, Chien, Wu-Chien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104207/ https://www.ncbi.nlm.nih.gov/pubmed/33950962 http://dx.doi.org/10.1097/MD.0000000000025756 |
Ejemplares similares
-
Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
por: Chen, Po-Huang, et al.
Publicado: (2022) -
Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience
por: Yen, Hung-Hsuan, et al.
Publicado: (2021) -
Tegafur-Uracil versus 5-Fluorouracil in Combination with Cisplatin and Cetuximab in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Analysis
por: Hsieh, Meng-Che, et al.
Publicado: (2021) -
Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer
por: Huang, Wen-Yen, et al.
Publicado: (2017) -
Characterization and Prognostic Significance of Methylthioadenosine Phosphorylase Deficiency in Nasopharyngeal Carcinoma
por: He, Hong-Lin, et al.
Publicado: (2015)